Is REGN a good stock to buy? We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. on r/investing_discussion by Variant_Invest. In this article, we will summarize the bulls’ thesis on REGN. Regeneron Pharmaceuticals, Inc.'s share was trading at $616.18 as of June 9th. REGN’s trailing and forward P/E were 15.51 and 14.16 respectively according to Yahoo Finance.
[caption id="attachment_564437" align="aligncenter" width="750"]Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.